Bio Vantage
High quality stock analysis on biotech and pharmaceutical companies
Tuesday, July 31, 2012
Qnexa received FDA approval on July 17, 2012
Vivus' drug Qnexa (renamed Qsymia) received FDA approval on July 17 for the treatment of obesity.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment